167 related articles for article (PubMed ID: 11500938)
1. Tissue specific metabolism of 1alpha,25-dihydroxy-20-epi-vitamin D3 into new metabolites with significant biological activity: studies in rat osteosarcoma cells (UMR 106 and ROS 17/2.8).
Siu-Caldera ML; Rao DS; Astecker N; Weiskopf A; Vouros P; Konno K; Fujishima T; Takayama H; Peleg S; Reddy GS
J Cell Biochem; 2001; 82(4):599-609. PubMed ID: 11500938
[TBL] [Abstract][Full Text] [Related]
2. Production of 1alpha,25-dihydroxy-3-epi-vitamin D3 in two rat osteosarcoma cell lines (UMR 106 and ROS 17/2.8): existence of the C-3 epimerization pathway in ROS 17/2.8 cells in which the C-24 oxidation pathway is not expressed.
Siu-Caldera ML; Sekimoto H; Weiskopf A; Vouros P; Muralidharan KR; Okamura WH; Bishop J; Norman AW; Uskoković MR; Schuster I; Reddy GS
Bone; 1999 May; 24(5):457-63. PubMed ID: 10321905
[TBL] [Abstract][Full Text] [Related]
3. 1alpha,25-dihydroxy-16-ene-23-yne-vitamin D3 and 1alpha,25-dihydroxy-16-ene-23-yne-20-epi-vitamin D3: analogs of 1alpha,25-dihydroxyvitamin D3 that resist metabolism through the C-24 oxidation pathway are metabolized through the C-3 epimerization pathway.
Reddy GS; Rao DS; Siu-Caldera ML; Astecker N; Weiskopf A; Vouros P; Sasso GJ; Manchand PS; Uskokovic MR
Arch Biochem Biophys; 2000 Nov; 383(2):197-205. PubMed ID: 11185554
[TBL] [Abstract][Full Text] [Related]
4. Enhanced biological activity of 1alpha,25-dihydroxy-20-epi-vitamin D3, the C-20 epimer of 1alpha,25-dihydroxyvitamin D3, is in part due to its metabolism into stable intermediary metabolites with significant biological activity.
Siu-Caldera ML; Sekimoto H; Peleg S; Nguyen C; Kissmeyer AM; Binderup L; Weiskopf A; Vouros P; Uskoković MR; Reddy GS
J Steroid Biochem Mol Biol; 1999 Dec; 71(3-4):111-21. PubMed ID: 10659699
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of selective 20-epi-vitamin D
Flarakos CC; Weiskopf A; Robinson M; Wang G; Vouros P; Sasso GJ; Uskokovic MR; Reddy GS
Steroids; 2017 Mar; 119():18-30. PubMed ID: 28089927
[TBL] [Abstract][Full Text] [Related]
6. Removal of C-ring from the CD-ring skeleton of 1alpha,25-dihydroxyvitamin D3 does not alter its target tissue metabolism significantly.
Reddy GS; Robinson M; Wang G; Palmore GT; Gennaro L; Vouros P; De Clercq P; Vandewalle M; Young W; Ling S; Verstuyf A; Bouillon R
Arch Biochem Biophys; 2007 Apr; 460(2):254-61. PubMed ID: 17196157
[TBL] [Abstract][Full Text] [Related]
7. 1alpha,25-dihydroxy-24-oxo-16-ene vitamin D3, a metabolite of a synthetic vitamin D3 analog, 1alpha,25-dihydroxy-16-ene vitamin D3, is equipotent to its parent in modulating growth and differentiation of human leukemic cells.
Siu-Caldera ML; Clark JW; Santos-Moore A; Peleg S; Liu YY; Uskoković MR; Sharma S; Reddy GS
J Steroid Biochem Mol Biol; 1996 Dec; 59(5-6):405-12. PubMed ID: 9010346
[TBL] [Abstract][Full Text] [Related]
8. Isolation, identification and biological activity of 24R,25-dihydroxy-3-epi-vitamin D3: a novel metabolite of 24R,25-dihydroxyvitamin D3 produced in rat osteosarcoma cells (UMR 106).
Kamao M; Tatematsu S; Reddy GS; Hatakeyama S; Sugiura M; Ohashi N; Kubodera N; Okano T
J Nutr Sci Vitaminol (Tokyo); 2001 Apr; 47(2):108-15. PubMed ID: 11508700
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of 2-methyl analogs of 1alpha,25-dihydroxyvitamin D3 in rat osteosarcoma cells (UMR 106).
Sunita Rao D; Siu-Caldera ML; Sekimoto H; Gennaro L; Vouros P; Takayama H; Konno K; Fujishima T; Reddy GS
Biol Pharm Bull; 2002 Jul; 25(7):845-52. PubMed ID: 12132655
[TBL] [Abstract][Full Text] [Related]
10. 1Alpha,25-dihydroxy-3-epi-vitamin D3, a natural metabolite of 1alpha,25-dihydroxy vitamin D3: production and biological activity studies in pulmonary alveolar type II cells.
Rehan VK; Torday JS; Peleg S; Gennaro L; Vouros P; Padbury J; Rao DS; Reddy GS
Mol Genet Metab; 2002 May; 76(1):46-56. PubMed ID: 12175780
[TBL] [Abstract][Full Text] [Related]
11. Isolation and identification of 1alpha-hydroxy-24-oxovitamin D3 and 1alpha,23-dihydroxy-24-oxovitamin D3: metabolites of 1alpha,24(R)-dihydroxyvitamin D3 produced in rat kidney.
Weinstein EA; Rao DS; Siu-Caldera ML; Tserng KY; Uskokovic MR; Ishizuka S; Reddy GS
Biochem Pharmacol; 1999 Dec; 58(12):1965-73. PubMed ID: 10591152
[TBL] [Abstract][Full Text] [Related]
12. Metabolism of 1alpha,25-dihydroxyvitamin D(3) in human promyelocytic leukemia (HL-60) cells: in vitro biological activities of the natural metabolites of 1alpha,25-dihydroxyvitamin D(3) produced in HL-60 cells.
Rao DS; Campbell MJ; Koeffler HP; Ishizuka S; Uskokovic MR; Spagnuolo P; Reddy GS
Steroids; 2001; 66(3-5):423-31. PubMed ID: 11179751
[TBL] [Abstract][Full Text] [Related]
13. C-3 epimerization of vitamin D3 metabolites and further metabolism of C-3 epimers: 25-hydroxyvitamin D3 is metabolized to 3-epi-25-hydroxyvitamin D3 and subsequently metabolized through C-1alpha or C-24 hydroxylation.
Kamao M; Tatematsu S; Hatakeyama S; Sakaki T; Sawada N; Inouye K; Ozono K; Kubodera N; Reddy GS; Okano T
J Biol Chem; 2004 Apr; 279(16):15897-907. PubMed ID: 14757768
[TBL] [Abstract][Full Text] [Related]
14. Metabolic stability of 3-epi-1α,25-dihydroxyvitamin D3 over 1 α 25-dihydroxyvitamin D3: metabolism and molecular docking studies using rat CYP24A1.
Rhieu SY; Annalora AJ; Wang G; Flarakos CC; Gathungu RM; Vouros P; Sigüeiro R; Mouriño A; Schuster I; Palmore GT; Reddy GS
J Cell Biochem; 2013 Oct; 114(10):2293-305. PubMed ID: 23606409
[TBL] [Abstract][Full Text] [Related]
15. 1Alpha,25-dihydroxy-3-epi-vitamin D3, a natural metabolite of 1alpha,25-dihydroxyvitamin D3, is a potent suppressor of parathyroid hormone secretion.
Brown AJ; Ritter C; Slatopolsky E; Muralidharan KR; Okamura WH; Reddy GS
J Cell Biochem; 1999 Apr; 73(1):106-13. PubMed ID: 10088729
[TBL] [Abstract][Full Text] [Related]
16. Characterization of 3-epi-1alpha,25-dihydroxyvitamin D3 involved in 1alpha,25-dihydroxyvitamin D3 metabolic pathway in cultured cell lines.
Masuda S; Kamao M; Schroeder NJ; Makin HL; Jones G; Kremer R; Rhim J; Okano T
Biol Pharm Bull; 2000 Feb; 23(2):133-9. PubMed ID: 10706373
[TBL] [Abstract][Full Text] [Related]
17. Isolation and identification of 1alpha-hydroxy-3-epi-vitamin D3, a potent suppressor of parathyroid hormone secretion.
Brown AJ; Ritter CS; Weiskopf AS; Vouros P; Sasso GJ; Uskokovic MR; Wang G; Reddy GS
J Cell Biochem; 2005 Oct; 96(3):569-78. PubMed ID: 16088954
[TBL] [Abstract][Full Text] [Related]
18. 1alpha,25-Dihydroxy-3-epi-vitamin D3 a physiological metabolite of 1alpha,25-dihydroxyvitamin D3: its production and metabolism in primary human keratinocytes.
Astecker N; Reddy GS; Herzig G; Vorisek G; Schuster I
Mol Cell Endocrinol; 2000 Dec; 170(1-2):91-101. PubMed ID: 11162893
[TBL] [Abstract][Full Text] [Related]
19. 1α,25(OH)2-3-epi-vitamin D3, a natural physiological metabolite of vitamin D3: its synthesis, biological activity and crystal structure with its receptor.
Molnár F; Sigüeiro R; Sato Y; Araujo C; Schuster I; Antony P; Peluso J; Muller C; Mouriño A; Moras D; Rochel N
PLoS One; 2011 Mar; 6(3):e18124. PubMed ID: 21483824
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D metabolism in human colon adenocarcinoma-derived Caco-2 cells: expression of 25-hydroxyvitamin D3-1alpha-hydroxylase activity and regulation of side-chain metabolism.
Cross HS; Peterlik M; Reddy GS; Schuster I
J Steroid Biochem Mol Biol; 1997 May; 62(1):21-8. PubMed ID: 9366495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
